✦ LIBER ✦

Radiotherapy results of unresectable hepatocellular carcinoma; A retrospective study of 158 patients

✍ Scribed by J. Seong; H.C. Park; K.H. Han; C.Y. Chon

Book ID: 117372524
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 159 KB
Volume: 38
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(03)80626-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selective radiotherapy of unresectable h

Selective radiotherapy of unresectable hepatocellular carcinoma

✍ Novell, JR; Hilson, A; Dusheiko, G; Green, A; Hobbs, K 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Clinical results of 3-dimensional confor

Clinical results of 3-dimensional conformal radiotherapy for unresectable hepatocellular carcinoma

✍ J. Seong; H.C. Park; S. Lee; S.S. Chu; C.O. Suh 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 16 KB

Radiotherapy for osseous metastases from

Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients

✍ Toshihide Kaizu; Katuyuki Karasawa; Yoshiaki Tanaka; Tadayoshi Matuda; Hiromasa 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 44 KB

A Retrospective Study of Radiotherapy fo

A Retrospective Study of Radiotherapy for Spinal Bone Metastases from Hepatocellular Carcinoma (HCC)

✍ Nakamura, N.; Igaki, H.; Yamashita, H.; Shiraishi, K.; Tago, M.; Sasano, N.; Shi 📂 Article 📅 2006 🏛 Oxford University Press 🌐 English ⚖ 216 KB

Phase II study of thalidomide in patient

Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma

✍ Albert Y. Lin; Nathalie Brophy; George A. Fisher; Sam So; Christopher Biggs; Tor 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

Phase 2 study of erlotinib in patients w

Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma

✍ Melanie B. Thomas; Romil Chadha; Katrina Glover; Xuemei Wang; Jeffrey Morris; Th 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

## Abstract ## BACKGROUND. Growth factor overexpression, including epidermal growth factor receptor (EGFR) expression, is common in hepatocellular cancers. Erlotinib is a receptor tyrosine kinase inhibitor with specificity for EGFR. The primary objective of this study was to determine the proporti